garyi said...
While the question is easy, the answer is both difficult and obscure. The reliable statistics on the use and benefits of ADT hormones to improve radiotherapy treatment are neither convincing or straight forward. At the same time, the side effects are alarming. There is a wide, and increasing, difference of opinions among radiation oncologists, even the best of them.
Sometimes we don't have a choice, but most of the time we do, so thread very carefully.
May you and your husband continue to enjoy a long life together, Nytngale.
Agree, treading carefully in any treatment choice is important, as is not taking the recommendations of every "study" with an eye-catching title. In this case, the article title alone could scare some away from ADT as an option of an additional therapy due to the fear of developing Alzheimer's, without consideration of their particular situation. My husband and I researched treatment options extensively and the risks/benefits of those options. He made his choices based on his situation and benefits that outweighed the risks of the treatment of choice. As I stated before, the risk of developing Alzheimer's as presented in this article is muddied by the multiple confounding variables i.e. age, comorbidities, physician accuracy in diagnosing Alzheimer's, timeliness of diagnosis, etc. Is the development of Alzheimer's (or more likely dementia which was displayed in a larger number) a possible risk of ADT, maybe. However, I wouldn't use the information in this article to make an iron-clad reason not to use the therapy. The concern needs far more research support in my opinion. In my husband's case, the risk of dying from his high-risk cancer far exceeds the worry over the risk of developing Alzheimer's.